Marksans Pharma informs about daily report regarding the equity shares bought back

02 Nov 2022 Evaluate

With reference to the Buyback of equity shares of Re 1 each of the company in terms of Securities and Exchange Board of India (Buyback of Securities) Regulations, 2018 (‘SEBI Buyback Regulations’) through open market using the Stock Exchanges Mechanism (‘Buyback’), Marksans Pharma has submitted the daily report pursuant to Regulation 18 of the SEBI Buyback Regulations regarding the Equity Shares bought back on November 1, 2022.

The above information is a part of company’s filings submitted to BSE.



Marksans Pharma Share Price

183.95 -3.95 (-2.10%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×